Bodyport is advancing the monitoring and management of patients with fluid management-related health conditions through simple daily measurements at home. The FDA-cleared Bodyport Cardiac Scale noninvasively measures weight, peripheral impedance, pulse rate, and balance. Bodyport’s connected software platform helps care teams interpret longitudinal patient trends, manage growing patient populations, and make more informed care decisions remotely.
With a single step, the FDA-cleared Bodyport Cardiac Scale measures hemodynamic signals through a patient’s feet and transmits the data over a cellular connection to the care team within minutes. Advanced sensors and proprietary algorithms non-invasively measure a wide range of metrics, providing a comprehensive view of heart health and fluid status from home.
The Bodyport Congestion Index combines multiple parameters captured by the Cardiac Scale into a single composite metric that provides insights into longitudinal changes associated with worsening congestion.* Presented alongside underlying measurements and trends, it helps healthcare professionals assess changes in clinical context, supporting more informed patient-management decisions.
*Results from SCALE-HF 1, a prospective, observational, multicenter study of 329 patients with heart failure followed for 238 patient-years. Elevated Congestion Index preceded 70% of adjudicated worsening heart failure events, compared with 35% using traditional weight-based rules.
Bodyport supports scalable remote patient monitoring through a standalone clinical portal with customizable monitoring rules, patient prioritization, and clear longitudinal trends. A flexible API and EHR integrations bring insights into existing clinical workflows, while optional patient-facing tools support engagement and a simple at-home experience. Built-in activity tracking and documentation support RPM program operations and billing workflows. The platform is designed to support HIPAA-compliant use and is independently assessed under SOC 2 Type 2.
The Bodyport technology has been evaluated through clinical studies conducted with leading health systems and research institutions, with findings published in peer-reviewed medical journals. Our commitment to evidence and clinical rigor informs every aspect of our work, from sensor development and algorithm design to clinical workflows and the patient experience. These collaborations help us deliver meaningful, reliable insights that support patient care.
